TreC-Onco

DEVICE2 trials

Sponsors

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Conditions

CancerHematologic MalignancyOral Drug AdministrationSolid Tumor

Unknown Phase

Participatory Research for Fine-tuning of a 2.0 System to Optimise Home Management of Oral Cancer Therapies.

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSCancer, Oral Drug Administration

Start: 2016-01-27End: 2021-05-31Updated: 2021-02-26

Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology

CompletedNCT04826458

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSCancer, Hematologic Malignancy, Oral Drug Administration +1

Start: 2021-05-04End: 2025-11-11Updated: 2025-12-03

Related Papers

A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training–Validation Trial

Journal of Medical Internet Research2022-01-268 citations

Use of the ONCO-TreC electronic diary compared with a standard paper diary to improve adherence to oral cancer therapy in patients with solid and haematological tumours: protocol for a randomised controlled trial

BMJ Open2022-01-011 citations

Optimisation and validation of a remote monitoring system (Onco-TreC) for home-based management of oral anticancer therapies: an Italian multicentre feasibility study

BMJ Open2017-05-0129 citations